Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Item
http://www.wikidata.org/entity/Q37548830
A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal CancerImpact of specific KRAS mutation in exon 2 on clinical outcome of chemotherapy- and radiotherapy-treated colorectal adenocarcinoma patients.Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusRetreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseNot all antibodies are equal.Role and mechanisms of resistance of epidermal growth factor receptor antagonists in the treatment of colorectal cancer.A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861.Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.
P2860

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Item
http://www.wikidata.org/entity/Q37548830
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@en
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@nl
type
label
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@en
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@nl
prefLabel
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@en
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Single agent panitumumab in KR ...... me and biomarkers of efficacy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932